Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      8 trials found for Urothelial, Bladder cancer

      All(8)
      Recruiting(8)
      Not yet recruiting(0)
      Recruiting
      NCT06285097
      A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

      Neoplasms, Non-small-cell Lung Cancer, Melanoma, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma, Urothelial Carcinoma, Colorectal Carcinoma, Ovarian Carcinoma

      Male or Female
      18+ years
      2study location(s)
      Recruiting
      NCT04389632
      A Study of SGN-B6A in Advanced Solid Tumors

      Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous

      Male or Female
      18+ years
      19study location(s)
      Recruiting
      NCT04879329
      A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

      Urothelial Carcinoma

      Male or Female
      18+ years
      57study location(s)
      Recruiting
      NCT05059522
      Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing

      Advanced Malignancies, NSCLC, Ovarian Cancer, Urothelial Cancer, Solid Tumors

      Male or Female
      18+ years
      32study location(s)
      Recruiting
      NCT05902494
      HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

      Urothelial Carcinoma

      Male or Female
      18+ years
      5study location(s)
      Recruiting
      NCT05911295
      Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

      Urothelial Carcinoma

      Male or Female
      18+ years
      24study location(s)
      Recruiting
      NCT05366725
      OBSERVATIONAL STUDY OF AVELUMAB AS FIRST-LINE MAINTENANCE TREATMENT OF PATIENTS WITH ADVANCED UROTHELIAL CANCER AFTER CHEMOTHERAPY

      Urothelial Cancer

      Male or Female
      18+ years
      2study location(s)
      Recruiting
      NCT03747419
      Avelumab and Radiation in Muscle-Invasive Bladder Cancer

      Bladder Cancer, Muscle Invasive Bladder Cancer

      Male or Female
      18+ years
      2study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(8)
      Recruiting(8)
      Not yet recruiting(0)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.